No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr18:28680200-28683000 |
Active TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
2 |
chr18:28682400-28683000 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
3 |
chr18:28682400-28683200 |
Flanking Active TSS |
iPS-18 Cell Line |
embryonic stem cell
|
4 |
chr18:28682400-28683200 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
5 |
chr18:28682400-28683600 |
Flanking Active TSS |
NHEK |
skin
|
6 |
chr18:28682600-28683000 |
Flanking Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
7 |
chr18:28682600-28683000 |
Enhancers |
Fetal Heart |
heart
|
8 |
chr18:28682600-28683000 |
Flanking Active TSS |
Fetal Intestine Small |
intestine
|
9 |
chr18:28682600-28683000 |
Flanking Active TSS |
Rectal Mucosa Donor 29 |
rectum
|
10 |
chr18:28682600-28683000 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
11 |
chr18:28682600-28683000 |
Flanking Active TSS |
HepG2 |
liver
|
12 |
chr18:28682600-28683200 |
Flanking Active TSS |
HUES48 Cell Line |
embryonic stem cell
|
13 |
chr18:28682600-28683200 |
Flanking Active TSS |
HUES64 Cell Line |
embryonic stem cell
|
14 |
chr18:28682600-28683200 |
Flanking Active TSS |
iPS-15b Cell Line |
embryonic stem cell
|
15 |
chr18:28682600-28683200 |
Flanking Active TSS |
iPS-20b Cell Line |
embryonic stem cell
|
16 |
chr18:28682600-28683200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
17 |
chr18:28682600-28683400 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
18 |
chr18:28682600-28683800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
19 |
chr18:28682600-28684600 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
20 |
chr18:28682600-28685400 |
Weak transcription |
Esophagus |
oesophagus
|
21 |
chr18:28682800-28683000 |
Flanking Active TSS |
ES-I3 Cell Line |
embryonic stem cell
|
22 |
chr18:28682800-28683000 |
Flanking Active TSS |
H1 Cell Line |
embryonic stem cell
|
23 |
chr18:28682800-28683000 |
Weak transcription |
H9 Cell Line |
embryonic stem cell
|
24 |
chr18:28682800-28683000 |
Flanking Active TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
25 |
chr18:28682800-28683000 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
26 |
chr18:28682800-28683000 |
Enhancers |
Fetal Intestine Large |
intestine
|
27 |
chr18:28682800-28683200 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
28 |
chr18:28682800-28683200 |
Enhancers |
Pancreatic Islets |
Pancreatic Islet
|
29 |
chr18:28682800-28683400 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
30 |
chr18:28682800-28683600 |
Enhancers |
Rectal Mucosa Donor 31 |
rectum
|
31 |
chr18:28682800-28683600 |
Enhancers |
K562 |
blood
|
32 |
chr18:28682800-28684000 |
Enhancers |
HMEC |
breast
|
33 |
chr18:28682800-28687200 |
Weak transcription |
Stomach Mucosa |
stomach
|